Table of Contents Table of Contents
Previous Page  231 / 1068 Next Page
Information
Show Menu
Previous Page 231 / 1068 Next Page
Page Background

Conclusions

1. 5FU-based CRT (45-50Gy) more effective

(downsizing) than RT but no improvement

in SpS, DFS or OS

2. Capecitabine is an equivalent option

3. Watch and wait remains experimental

4. Radio-sensitizing 5FU-based CRT not

improved by additional oxaliplatin ?

5. Biologicals have not yet delivered

6. Postop adjuvant chemotherapy after SCPRT

or CRT remains of unproven benefit